NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
This seems as a low risk entry here at 50 days, should rebound if the market continues higher after the previous last week pullback
The market was showing a reversal for most of Friday. Looking for a continuation on Monday.
IBD rating of 98
RS rating 94
Long @ 610.37

Keep it simple: price action and volume
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。